January 11, 2024 C-Path to Lead New Task Force Aimed at Accelerating Drug Development for Mitochondrial and Inherited Metabolic Diseases Critical Path Institute (C-Path) today announced the launch of a task force focused on accelerating drug...
December 12, 2023 C-Path’s RDCA-DAP Program and PicnicHealth Announce Data Collaboration to Accelerate Rare Disease Research TUCSON, Ariz., December 12, 2023 – Critical Path Institute (C-Path), a leader in advancing rare disease research, is pleased to
December 12, 2023 C-Path Welcomes Mucopolysaccharidosis Clinical Trial Data Contribution from Children’s Hospital of Orange County into RDCA-DAP TUCSON, Ariz., December 12, 2023 – C-Path (Critical Path Institute) is thrilled to announce a significant addition to its Rare D
October 26, 2023 C-Path and Congenital Hyperinsulinism International Announce Data Sharing Agreement TUCSON, Ariz., October 26, 2023 — Critical Path Institute (C-Path) and Congenital Hyperinsulinism International (CHI), a leading
October 3, 2023 C-Path Rare and Orphan Disease Conference Highlights Unprecedented Collaborations and Breakthroughs in Rare Disease Research TUCSON, Ariz., October 3, 2023 — The Critical Path Institute (C-Path) held its highly anticipated Rare and Orphan Disease Confer
September 12, 2023 C-Path’s Rare Disease Clinical Outcome Assessment Consortium Launches Rare Disease COA Resource The Rare Disease COA Resource aims to simplify COA selection for use in rare disease drug development. TUCSON, Ariz., Septe
August 15, 2023 NORDs’ IAMRARE Registry Contributes Two New Datasets to C-Path’s RDCA-DAP, Boosting Rare Disease Research and Therapeutic Advancement TUCSON, Ariz., August 15, 2023 — Critical Path Institute (C-Path) announced today that the National Organization for Rare Disord
July 19, 2023 The Foundation for Angelman Syndrome Therapeutics to Contribute Data to C-Path’s RDCA-DAP, Accelerating Neurological Disease Research and Therapeutic Development TUCSON, Ariz., July 19, 2023 — Critical Path Institute (C-Path) announced today that the Foundation for Angelman Syndrome Therap
July 18, 2023 C-Path Integrates European Offices to Optimize Global Operations and Collaborative Partnerships AMSTERDAM and TUCSON, Ariz., July 18, 2023 — Critical Path Institute (C-Path) announced today the completion of the integration
July 12, 2023 Sanford Health Rare Disease Data Registry Partners with C-Path’s RDCA-DAP, Cure Mito Foundation to Aggregate Rare Disease Data in Platform TUCSON, Ariz., July 12, 2023 — Critical Path Institute (C-Path) announced today that the Coordination of Rare Diseases based at